InVivoMab anti-mouse BTLA (CD272) BE0132-R050mg from Bio X Cell | Biocompare.com

Supplier Images

InVivoMab anti-mouse BTLA (CD272)
InVivoMab anti-mouse BTLA (CD272)

InVivoMab anti-mouse BTLA (CD272)

Be the first to write a review!

Citations:

Supplier Page from
Bio X Cell for
InVivoMab anti-mouse BTLA (CD272)

Bio X Cell's InVivoMab anti-mouse BTLA (CD272) is a Hamster monoclonal antibody. The InVivoMab anti-mouse BTLA (CD272) Antibody was generated using BTLA as the antigen. It reacts with Mouse. This antibody has been shown to work in applications such as: In Vivo, Block/Neutralize/Inhibit, and Functional Assay.

Description

Bio X Cell InVivoMAb anti-mouse BTLA (CD272) Monoclonal Antibody has the following reported applications: in vivo BTLA stimulation, in vivo BTLA blockade. It features greater than 95% purity, ultra-low endotoxin levels, and are preservative, stabilizer, and carrier protein-free

Product Specs
ItemInVivoMab anti-mouse BTLA (CD272)
CompanyBio X Cell
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberBE0132-R050mg
Quantity50 mg
Applicationsin vivo BTLA stimulation, in vivo BTLA blockade
ConcentrationLot specific,typically between 4-11 mg/ml
Conjugate/TagUnconjugated
ReactivityMouse
TargetBTLA
IsotypeIgG, κ
Clone6A6
HostArmenian hamster
NCBI Full Gene NameB and T lymphocyte associated
NCBI Gene AliasesA630002H24
ClonalityMonoclonal
ImmunogenC57BL/6 mouse BTLA Ig domain
Antibody TypePrimary Antibody
Purity>95%, Determined by SDS-PAGE
FormatPBS, pH 7.0, Contains no stabilizers or preservatives
Research AreaCancer Biology, Immune Checkpoint Protein, Immunology

Specifications/Features

Other available quantities: Available in 1, 5, 10, 25, 50, 100 mg and bulk sizes. Academic discount available.

Endotoxin: <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay

Add to Compare List

Bio X Cell

Bio X Cell

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bxcell.com

Company Profile

Website: bioxcell.com

(1) The inhibitory receptor BTLA controls γδ T cell homeostasis and inflammatory responsesImmunityDecember 12, 2013Bekiaris V, Šedý JR, Macauley MG, Rhode-Kurnow A, Ware CF.

(2) Therapeutic potential of B and T lymphocyte attenuator expressed on CD8+ T cells for contact hypersensitivityThe Journal of investigative dermatologyMarch 1, 2013Nakagomi D, Suzuki K, Hosokawa J, Kobayashi Y, Suto A, Takatori H, Watanabe N, Matsue H, Murphy TL, Murphy KM, et al.

(3) BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infectionPloS oneJanuary 1, 2013Steinberg MW, Huang Y, Wang-Zhu Y, Ware CF, Cheroutre H, Kronenberg M.

(4) Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cellsBloodDecember 6, 2012Tewalt EF, Cohen JN, Rouhani SJ, Guidi CJ, Qiao H, Fahl SP, Conaway MR, Bender TP, Tung KS, Vella AT, et al.

(5) Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malariaJournal of immunology (Baltimore, Md. : 1950)September 15, 2007Lepenies B, Pfeffer K, Hurchla MA, Murphy TL, Murphy KM, Oetzel J, Fleischer B, Jacobs T.

Be the First to Write a Review!